Page results
-
This information is for patients who have attended the emergency department with an undisplaced or minimally displaced fracture (broken bone) at the base of your 5th metatarsal.
-
This page provides information about the use of venous sinus stents in the treatment of venous sinus stenosis and idiopathic intracranial hypertension (IIH).
-
This page provides information about endovascular treatment of Subdural Hematomas (SDH).
-
This page provides information about the sclerotherapy for low flow vascular malformations.
-
Tasnim tells us about her experience training with the Pharmacy team at UCLH and how their support has encouraged her to pursue this career.
-
Today we are launching the new UCLH strategy for 2023-2027. Developed with staff, patients and key partners, the strategy sets the future direction of UCLH over the next five years.
-
This page provides an overview of our Teenage and Young Adult (TYA) Ambulatory Care Service available to patients aged 12 to 24 years.
-
This diary is intended for patients undergoing thoracic surgery as a way of involving you in your recovery before your surgery as well as after.
-
Information for patients undergoing VATS for drainage of air or fluid, pleural biopsies and talc pleurodesis.
-
Information for patients having VATS/Thoracotomy procedure.
File results
-
FOI/2022/0546 - Metastatic Cholangiocarcinoma (CCA) or Acute myeloid leukaemia
-
FOI/2022/0548 - Biologic and biosimilar products within Rheumatology
-
FOI/2022/0549 - SACT (systemic anti-cancer therapy) /cervical cancer treatments
-
FOI/2022/0550 - Patients that have been treated for glioblastoma brain cancer
-
FOI/2022/0553 - Patients tested for non-small cell lung cancer biomarkers
-
FOI/2022/0561 - Regulation (EU) 2016/425 Declarations of Conformity for all type IIR surgical masks provided as PPE to staff
-
FOI/2022/0571 - Treatment for biologic medicines in Dermatology
-
FOI/2022/0572 - Treatments for Hidradenitis Suppurativa and Psoriasis
-
FOI/2022/0573 - Use of WhatsApp by or within the Trust
-
FOI/2022/0513 - Myelofibrosis treatment